🍬 GLP-1 RA & SGLT2 Inhibitor Planner
Perioperative management — Based on ASA and Endocrinology guidelines
Medication Class
Based on Goldenberg et al., 2025 Current Medical Research and Opinion (doi:10.1080/03007995.2025.2458538), AHA/ACC/ACS/ASNC/HRS/SCA/SSCT/SCMR/SVM 2024 Guidelines (doi:10.1161/cir.0000000000001285), and ASA 2024 guidelines (doi:10.1016/j.cgh.2024.10.003).
For clinical reference only. Always apply independent clinical judgment.